Affiliations: Department of Pediatrics, Faculty of Medicine, Minia University, Minia, Egypt | Department of Pediatrics, College of Medicine, King Khalid University, Abha, Saudi Arabia | Department of Biochemistry, Abha General Hospital, Abha, Saudi Arabia
Note:  Corresponding author: Dr. Walid Abdel Wahab Mohamed, Department of Pediatrics, College of Medicine, King Khalid University, Abha, P.O. Box 641, Saudi Arabia. Tel.: +966 502507894; Fax: +966 72418194; E-mail: email@example.com
Abstract: OBJECTIVE: To evaluate fibroblast growth factor-10 (FGF-10) levels in cord blood as a possible predictor of the subsequent development of bronchopulmonary dysplasia (BPD) in preterm infants. PATIENTS AND METHODS: A total of 269 preterm (≤32 weeks gestation) infants (76 infants developed BPD and 193 had no BPD) were enrolled. FGF-10 levels were measured by enzyme-linked immunosorbent assay. RESULTS: Preterm infants who subsequently developed BPD had significantly lower cord serum levels of FGF-10 than those who did not (p < 0.001). Cord blood levels of FGF-10 were significantly lower in infants with severe BPD than those with moderate or mild disease (p < 0.001). Logistic regression analysis demonstrated that low cord blood FGF-10 level was independently associated with the subsequent risk of BPD (OR = 0.978 [95 % CI: 0.959 – 0.997]; p = 0.02). CONCLUSION: Low cord blood FGF-10 levels may predict the subsequent development of BPD in preterm infants.